Suppression of transforming growth factor-β (TGFβ) and TGFβ receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 9, 1996, Pages 3222-3230

  Dou, Qingchuan ^a   Zhao, Yong ^a   Tarnuzzer, Roy W ^a   Rong, Hui ^a   Williams, R Stan ^a   Schultz, Gregory S ^a   Chegini, Nasser ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GONADORELIN AGONIST; LEUPRORELIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LEIOMYOMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS MYOMA;

ADULT; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEIOMYOMA; LEUPROLIDE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; TRANSFORMING GROWTH FACTOR BETA; UTERINE NEOPLASMS;

EID: 0029845934     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.9.3222     Document Type: Article

References (25)

1. Wilcox LS, Koonin LM, Pokras R, Struss LT, Xia Z, Peterson HE. 1994 Hysterectomy in the united states, 1988-1990. Obstet Gynecol. 83:549-555.
2. Buttram VC, Reiter RC 1981 Uterine leiomyomata: etiology, symptomatology and management. Fertil Steril. 36:433-445.
3. Vollenhoven BJ, Lawrence AS, Healy DL. 1990 Uterine fibroids: a clinical review. Br J Obstet Gynaecol. 97:258-298.
4. Rein MS, Barbieri RL, Friedman AJ. 1995 Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol. 172:14-18.
5. Kawaguchi K, Fujj S, Konishi I, Nanbu Y, Nonogaki H, Mon T. 1989 Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol. 160:637-641.
6. Chrapusta S, Sieinski W, Konopka B, Szamborski J, Faszko Z. 1990 Estrogen and progestin receptor levels in uterine leiomyomata: relation to the tumor histology and the phase of menstrual cycle. Eur J Gynecol Oncol. 11:381-387.
7. Chrapusta S, Konopka B, Paszko Z, Sieinski W, Szamborski J. 1990 Immunoreactive and estrogen-binding estrogen receptors, and progestin receptor levels in uterine leiomyomata and their parental myometrium. Eur J Gynecol Oncol. 11:275-281.
8. Branden DD, Bethea CL, Strawn EY, et al. 1993 Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol. 169:78-85.
9. Bulum SE, Simpson ER, Word RA. 1994 Expression of the CYP19 gene and its products aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J Clin Endocrinol Metab. 78:736-743.
10. Rein MS, Friedman AJ, Stuart JM, MacLaaughlin DY. 1990 Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril. 53:1018-1023.
11. Pasqualini JR, Cornier E, Grenier J, Vella C, Schatz B, Netter A. 1990 Effect of decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium. Fertil Steril. 53:1012-1017.
12. Lumsden MA, West CP, Hawkins RA, Bramley TA, Rumgay L, Baird DT. 1989 The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630). J Endocrinol. 121:389-396.
13. Upadhyaya NB, Doody MC, Googe PB. 1990 Histological changes in leiomyomata treated with leuprolide acetate. Fertil Steril. 54:811-814.
14. 125I-epidermal growth factor in human uterus. Cell Tissue Res. 246:543-548.
15. Hoffmann GE, Rao ChV, Barrows GH, Schultz GS, Sanfilippo JS. 1984 Binding sites for epidermal growth factor in human uterine tissues and leiomyomas. J Clin Endocrinol Metab. 58:880-884.
16. Tommola P, Pekonen F, Rutanen EM. 1989 Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata. Obstet Gynecol. 74:658-662.
17. Yeh J, Rein M, Nowak R. 1991 Presence of messenger ribonucleic acid for EGF and EGF receptor demonstrable in monolayer cell cultures of myometrial and leiomyomata. Fertil Steril. 56:997-1000.
18. Rossi MJ, Chegini N, Masterson BJ. 1992 Presence of EGF, PDGF and their receptors in human myometrial tissue and smooth muscle cells:Their action in smooth muscle cells in vitro. Endocrinology. 130:1716-1727.
19. Fayed YM, Tsibsis JCM, Langenberg PW, Robertson AL. 1989 Human uterine leiomyoma cells: binding and growth responses to EGF, platelet-derived growth factor, and insulin. Lab Invest. 60:30-37.
20. Gudice LC, Irwin JC, Dsupin BA, et al. 1993 Insulin-like growth factor (IGF), IGF binding protein (IGFBP) and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum Reprod. 8:1796-1806.
21. Gloudemans T, Prinsen I, Van Unnik JA, Lips CJ, den Otter W, Sussenbach JS. 1990 Insulin-like growth factor gene expression in human smooth muscle tumors. Cancer Res. 50:6689-6695.
22. Chandrasekhar Y, Heimer J, Osuamkpe C, Nagamani M. 1992 Insulin-like growth factor I and II binding in human myometrium and leiomyomas. Am J Obstet Gynecol. 166:64-69.
23. Tang X-M, Rossi MJ, Masterson BJ, Chegini N. 1994 Insulin-like growth factor I (IGF-I), IGF-I receptors and IGF binding proteins 1-4 in human uterine tissue: tissue localization and IGF-I action in endometrial stromal and myometrial smooth muscle cells in vitro. Biol Reprod. 50:1113-1125.
24. Rein MS, Friedman AJ, Pandian MR, Heffner LJ. 1990 The secretion of insulin-like growth factors I and II by explant cultures of fibroids and myo-metrium from women treated with a gonadotropin-releasing hormone agonist. Obstet Gynecol. 76:388-394.
25. Lumdsden MA, West CP, Bramley TA, Rumgay L, Baird DT. 1988 The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypoestrogenic by continuous administration of an LhRH agonist. Br J Obstet Gynaecol. 95:1299-1304.